Medication – Kepplah Thu, 10 Jun 2021 12:04:27 +0000 en-US hourly 1 Medication – Kepplah 32 32 US Online Pharmacy Market Report 2021-2026: Increase Thu, 10 Jun 2021 11:33:43 +0000

Dublin, June 10, 2021 (GLOBE NEWSWIRE) – The “US Online Pharmacy Market – Industry Outlook and Forecast 2021-2026” report was added to offer.

The US online pharmacy market in terms of revenue is expected to grow at a CAGR of approximately. 19% over the period 2020-2026.

Automated prescription filling, automated customer relationship management, direct selling of drugs to patients are other major factors that are increasing the uptake of online pharmacies in the United States.

The market is moving towards the direct-to-patient model as the ever-expanding digital world opens doors to new services and user-friendly online experiences. The ease and familiarity of shopping online prompts many patients to seek out virtual care drugs and wellness options.

This has prompted online pharmacies to advertise more and acquire more consumers through digital platforms. The COVID-19 pandemic has further accelerated this change, as most healthcare professionals and patients have adapted to the virtual way of buying drugs. The trend is expected to increase dramatically in the United States after COVID-19.


The United States Online Pharmacy Market research report comprises detailed segmentation by drug type, product, modality, and pharmacy type. The US prescription online pharmacy market is expected to exceed $ 132 billion by 2026.

Profitability is an important factor in the growth of prescription drugs via the online mode. Consumers prefer to buy drugs from online stores because they offer drugs at lower prices than retail outlets. Among American adults taking prescription drugs, 1.5% reported purchasing drugs outside of the United States because of the high costs. Hence, online pharmacies are considered to be the best solution to provide prescription drugs at discounted prices, thus watching the growth.

In 2020, the drug segment represented approx. 76% market share of online pharmacies in the United States. The increase in the patient population as well as the increase in the geriatric population increases the demand for drugs. There is an increase in consumers preferring online pharmacy platforms to purchase drugs due to the great convenience of purchasing. Many customers and patients prefer to use online pharmacies to stock up on long-term medications.

The mobile application based segment is likely to grow at a CAGR of over 19% from 2020 to 2026. Mobile applications play an important role in the global online pharmacy market. They help online pharmacies get in direct contact with consumers, thereby increasing the patient base. Mobile applications help online pharmacies to effectively position their pharmacies.

Mobile apps offering prescription refills, secure two-way messaging, and a HIPAA-compliant mobile app will increase the number of online pharmacies. Providers prioritize digital advertising and marketing to attract more audiences, as many patients spend their time online.

The US online pharmacy market by the online brick and mortar branch expects to reach approx. $ 80 billion by 2026. Most retail businesses in the United States tend to have an online channel to promote their products and increase their customer base. This trend has prevailed in the United States for a long time. However, during the COVID-19 pandemic, the country further accelerated the adoption of online pharmacy channels.


The US online pharmacy market is experiencing a constant flow of start-ups entering the industry. The COVID-19 pandemic has increased the importance of online pharmacies in the country.

Many doctors, patients and health care providers have increased the adoption of telehealth, which has increased the number of teleconsultations in the country. Large hospitals received 500% more online consultations and electronic prescriptions among healthcare providers also increased.

These factors have accelerated the growth of the online pharmacy market in United States. A shift in consumer behavior patterns has increased the growth opportunities in the market. However, strict adherence to regulatory guidelines and the prevalence of counterfeiting and bogus websites selling unhealthy products are hampering the market.

Kroger, CVS Health, CIGNA (Express Scripts), Walgreens Boots Alliance and Rite Aid are the main players in the US online pharmacy market.

Leading suppliers

  • Kroger
  • CVS Health
  • CIGNA (Express Scripts)
  • Alliance of Walgreens boots
  • Rite Help

Other important suppliers

  • Alto pharmacy
  • Flashing Health
  • BioPlus Specialized Pharmacy
  • Drug Batell
  • Carepoint pharmacy
  • Foundation care
  • Fruth Pharmacy
  • Giant eagle
  • Health warehouse
  • High school pharmacy
  • Health for him and for her
  • Henry Ford Health System
  • Kinney Drugs
  • KwikMed
  • MedVantx
  • Medicine
  • Medly Pharmacy
  • Pharmacie du
  • OptumRx
  • Pillbox
  • Pharmacy Ro
  • Walmart Stores
  • Woori pharmacy

Main topics covered:

1 Research methodology

2 Research objectives

3 Research process

4 Scope and coverage

5 Hypotheses and caveats in the report
5.1 Key caveats
5.2 Currency conversion
5.3 Market derivation

6 Market overview

7 Presentation
7.1 Overview
7.2 Impact of COVID-19 on Us Online Pharmacy
7.3 Regulations for online pharmacies in the United States
7.4 Comparison of Electronic Pharmacy in US Market vs Global Market
7.5 Online pharmacy start-ups and their investments

8 Market opportunities and trends
8.1 Increase in direct sales of drugs to patients
8.2 Increased demand for advanced e-commerce technologies
8.3 High adoption of electronic prescriptions among US customers

9 market growth catalysts
9.1 Increase in teleconsultation and diagnostic assistance
9.2 Growing Penetration of Internet and Mobile Applications
9.3 High adoption of automated prescription renewal and CRM solutions

10 market restrictions
10.1 Sale of unapproved drugs and FDA warnings
10.2 Competition from traditional and medical product retailers
10.3 Strict regulatory framework for the online sale of medicines

11 Market landscape
11.1 Market overview
11.2 Market Size and Forecast
11.3 Analysis of the five forces

12 Type of drug
12.1 Market Overview and Growth Driver
12.2 Market overview
12.3 Prescription
12.4 Over The Counter (OTC)

13 Product
13.1 Market Overview and Growth Driver
13.2 Market overview
13.3 Medicines
13.4 Health, well-being and nutrition
13.5 Personal care

14 Modality
14.1 Market Overview and Growth Driver
14.2 Market overview
14.3 Mobile application
14.4 Web Based

15 Type of pharmacy
15.1 Market Overview and Growth Driver
15.2 Market overview
15.3 Online branch of the Brick & Mortar pharmacy
15.4 Independent online pharmacies only
15.5 Partnership site with neighborhood pharmacies

16 Competitive landscape
16.1 Competition overview
16.2 Market share analysis

For more information on this report, visit


Source link

]]> 0
Liquid diet for T2DM lowers blood pressure and reduces drug use Wed, 09 Jun 2021 19:46:55 +0000

Liquid Total Diet Replacement (TDR) provided approximately 830 kcal / day with automatic reductions in all nutrients to induce rapid weight loss over 12 to 20 weeks. Antihypertensive drugs were withdrawn at the start of the regimen and BP was monitored regularly. The reintroduction of treatment was based on clinical guidelines.

Participants were randomized to an intervention or control group and all had been diagnosed with T2DM within the past 6 years. Other inclusion criteria included a glycated hemoglobin level of ≥ 6.5%, or ≥ 6.1% if on T2DM treatment, aged 18 to 65, and a body mass index (BMI) of 27 to 45 kg / m2.

Of 143 participants, 62 did not have hypertension and 81 did; of these 81 patients, 78 were taking antihypertensive drugs.

Of the 78, most stopped taking their medication completely at the start of the regimen, and 9 did not.

The overall mean BP decreased significantly from the start of the RDT and was significantly lower when the total diet replacement of the RDT ended at week 20. It remained below 12 and 24 months.

Of the 78 participants previously on treatment for hypertension, 65 (83%) stopped all antihypertensive and diuretic drugs according to protocol, and 4 stopped certain drugs.

These 69 participants saw no immediate BP change, but their average BP dropped significantly from 9 weeks onwards. While BP did not increase excessively, antihypertensive drugs were reintroduced during RDT to manage the increase in BP for 27.5% of the participants, even though they lost weight.

Participants who took 2 medications, as opposed to 1, were more likely to need to reintroduce their BP therapies.

At 24 months, 28% of those who stopped their antihypertensive therapy did not take any.

Of the 53 participants who achieved remission from T2DM through diet, 31 had previously been treated for hypertension.

The researchers said that although the protocol was safe and effective, careful monitoring of BP is necessary; 51 participants reported mild to moderate dizziness during RDT, suggesting orthostatic hypotension. Of these participants, 15 had a history of dizziness before starting the diet.

The study was carried out by researchers from the universities of Glasgow and Newcastle.

“We wanted to assess the safety and effectiveness of withdrawing hypertension medication at the start of our weight loss program designed specifically for type 2 diabetes, and we are really happy with the results,” Mike Lean, MD , MA, MB, FRCPS, FRSE, University of Glasgow Principal Clinical Investigator said in a press release. “Our study shows that in addition to possible remission of type 2 diabetes, there are other very important health benefits, as weight loss is a very effective treatment for hypertension and the serious risks for it. health associated with it. “


Leslie WS, Ali E, Harris L. et al. Antihypertensive Drug Needs and Blood Pressure Control with Weight Loss in the Diabetes Remission Clinical Trial (DiRECT). Diabetology. Published online May 31, 2021. doi: 10.1007 / s00125-021-05471-x

Source link

]]> 0
Indian hypochondriacs make self-medication a deadly second-wave problem Wed, 09 Jun 2021 03:58:20 +0000

Representative image | Here

Text size:

New Delhi: At the end of April, a patient approached Dr Ashwani Goyal, a general practitioner in Delhi, breathless. The patient had all the obvious symptoms of Covid-19 and eventually succumbed to the disease. Seeing a doctor sooner might have saved his life, but he only got to Dr Goyal’s door when his condition became critical. This is a trend that Goyal observed often during the Covid-19 pandemic.

“He took a prescription from a family member, written by a pulmonologist, and immediately started taking these drugs instead of seeing the doctor first. By the time he came to see me, his oxygen was at 72 and I had to refer him elsewhere. I found out later that he was dead, ”Dr Goyal told ThePrint. “This is not a stray case, there are countless such cases,” he added.

Among the medications the patient had started, Goyal said, was the antiparasitic ivermectin, in addition to the antibiotics doxycycline and azithromycin.

In the revised guidelines issued on May 27 by the General Directorate of Health Services (DGHS), which reports to the Union Ministry of Health and Family, the mention of these drugs had been deleted, just like that of hydroxychloroquine, zinc and vitamins, although the latest rules set out on the The ministry of health (updated May 24) and Indian Council of Medical Research (May 3) websites suggest otherwise.

As the second wave of Covid took hold in India and flooded hospitals, many patients resorted to self-medication, which was also reported in the first wave. Prescriptions were shared among acquaintances on WhatsApp, and people anxious to develop severe Covid infection skipped the pills, often without individual medical consultation.

Doctors say lax oversight in pharmacies has fueled the trend, and constant updates to government guidelines – which typically define when a drug cannot be administered without medical supervision – have fueled the confusion.

“The guidelines changed quite frequently, which made the situation very confusing for doctors and patients,” said Dr. Goyal, adding, “Over time, we can see changes in the way people work. self-care, but they will continue to exchange prescriptions on WhatsApp and consult their friends. It happened before Covid too. “

Read also : “Fearing Covid”, Indians burst ivermectin, HCQ, dexamethasone – all self-prescribed

Why patients self-medicate

As noted by Dr Goyal, Indians have been associated with a propensity for self-medication, the side effects of which include side effects and drug resistance.

A 2020 meta-analysis from 17 self-medication articles in India found that the practice had an average prevalence rate of 53.57 percent, and that the most common reasons for self-medication included minor ailments and familiarity with medications. Another reason given was “the lack of regulation of over-the-counter drugs and the failure to adhere to rational drug use practices and policies”.

Doctors say the pandemic has exacerbated these trends, aided by social media, changing drug guidelines, increased health anxiety and a bombardment of information about new drugs and treatments for Covid- 19.

“Initially, it was hydroxychloroquine, then it became ivermectin and doxycycline, then azithromycin. Now it’s remdesivir and steroids, ”said Dr Jugal Kishore, head of community medicine at Safdarjung Hospital in Delhi.

“Pharmacies distributed them to people in packs, sometimes mixing them with Ayurvedic treatments like Coronil.”

Like Goyal, Dr Kishore says government guidelines are for doctors and people to follow, but cannot be strictly enforced.

Dr Rajeev Jayadevan, endocrinologist and former president of the Indian Medical Association, who has lectured several times on irrational drug use during the pandemic, described the trend towards self-medication – and over-medication – as a vicious cycle .

“When patients turn to doctors, they expect them to ‘do something’ – prescribe medication, in other words. It’s not uncommon for doctors to be asked why they don’t prescribe certain drugs, ”said Dr Jayadevan. “Doctors and patients compare prescriptions with each other, which has created a sort of unhealthy vicious cycle. The immediate availability of drugs in pharmacies and the lack of strict regulations allowed this to happen. “

Role of mental health

Patients with particular health concerns can also visit online forums and discussion forums, in addition to looking for online consultations.

“A patient will usually come to the hospital physically when he has really good reasons to do so. But with online consultations, doctors are just a phone call away. I am getting more and more calls for minor issues and from overly cautious people, ”said Dr Sampath Chandra Prasad Rao, cranial surgeon at Manipal Hospitals in Karnataka.

“The very fact that people resort to online consultations, when they are superfluous, indicates that people are anxious about Covid and other diseases. I know many around me who suffer from this anxiety.

Doctors from the Government Institute of Medical Sciences (GIMS), Noida, have found a strong bond between health anxiety and the tendency to self-medicate. The study, conducted during the first wave of Covid-19 in 2020, included an online survey. Of the 1,100 responses, a quarter “of respondents reported self-medication, 60% of which were anxious”.

Among those who self-treated, 56.6% were doing it for the first time, according to the study. “The drugs were taken mainly for symptoms such as headache, abdominal pain, ghabrahat (anxiety) and inability to sleep, ”the study added.

The most commonly used drugs were nonsteroidal anti-inflammatory drugs, such as aspirin and ibuprofen.

“We did this study in the first wave, it must be a lot worse now,” Dr. Bharti Bhandari, one of the study’s co-authors, told ThePrint.

Read also : Self-medication for Covid has become disastrous. Families should not take on the role of doctors

Subscribe to our channels on Youtube & Telegram

Why the news media is in crisis and how to fix it

India needs free, fair, uninhibited and questioning journalism even more as it faces multiple crises.

But the news media are in a crisis of their own. There have been brutal layoffs and pay cuts. The best of journalism is shrinking, giving in to crass spectacle in prime time.

ThePrint employs the best young reporters, columnists and editors. Supporting journalism of this quality requires smart, thoughtful people like you to pay the price. Whether you live in India or abroad, you can do it here.

Support our journalism